PD-137889 is a chemical compound classified as an arylcyclohexylamine derivative. This compound is a structural analogue of phencyclidine (PCP), sharing a similar chemical backbone but featuring modifications that distinguish it within the same family. PD-137889 is known to act as a dissociative anesthetic and an NMDA receptor antagonist, making it of interest in pharmacological and neurochemical research.
Key Characteristics of PD-137889:
- NMDA Receptor Antagonism: PD-137889 blocks NMDA receptors in the central nervous system, which are involved in synaptic plasticity, learning, and memory.
- Chemical Structure: It is similar to PCP but with structural differences that may alter its potency, binding affinity, and pharmacological profile.
- Research Significance: PD-137889 is primarily studied for its effects on neural pathways, dissociative mechanisms, and potential therapeutic applications.
Research Applications:
PD-137889 is utilized in:
- Neuropharmacology: Studying the role of NMDA receptors in neural activity and dissociative states.
- Receptor Binding Studies: Exploring how structural analogues of PCP interact with various receptor sites.
- Toxicological Research: Understanding the safety profiles and potential side effects of dissociative anesthetics.
Important Information:
PD-137889 is intended for research purposes only and is not approved for human or veterinary use. It should be handled by qualified professionals in controlled laboratory environments.
Reviews
There are no reviews yet.